Compare BTBT & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BTBT | TNDM |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.5B |
| IPO Year | 2018 | 2013 |
| Metric | BTBT | TNDM |
|---|---|---|
| Price | $2.08 | $21.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 16 |
| Target Price | $6.50 | ★ $22.44 |
| AVG Volume (30 Days) | ★ 33.7M | 2.3M |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | $105,703,143.00 | ★ $1,007,001,000.00 |
| Revenue This Year | $7.04 | $8.59 |
| Revenue Next Year | $96.28 | $10.19 |
| P/E Ratio | $3.62 | ★ N/A |
| Revenue Growth | 7.86 | ★ 17.87 |
| 52 Week Low | $1.69 | $9.98 |
| 52 Week High | $4.72 | $38.28 |
| Indicator | BTBT | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 36.29 | 66.05 |
| Support Level | $2.23 | $20.27 |
| Resistance Level | $2.48 | $22.10 |
| Average True Range (ATR) | 0.17 | 1.12 |
| MACD | 0.04 | -0.08 |
| Stochastic Oscillator | 5.81 | 91.59 |
Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.